Pharmacology & ToxicologybioRxivPreprint
CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action
C. W. White, L. E. Kilpatrick, N. Dale…·S. J. Hill
This study identifies CXCL17 as an endogenous inhibitor of CXCR4 through a novel mechanism involving interaction with neuropillin-1 and glycosaminoglycan binders.
DOI 10.1101/2021.07.05.451109